Novo Nordisk A/S shares plunged ~25% after sharply lowered 2026 revenue and profit guidance. Learn more about NOVO:CA stock here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results